The 12th European PRRS Research Awards
Discover the winners
COMBAT - Updated biosecurity tool with 4 features
Read now
The Guilty Gilt Guide
Read now
PRRS Ctrl 2.0
Download for free
The 12th European PRRS Research Awards
COMBAT - Updated biosecurity tool with 4 features
The Guilty Gilt Guide
PRRS Ctrl 2.0
April 2026
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
May 2026
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
June 2026
01
02
PRRSV detection by qPCR in processing fluids and serum samples collected in a positive stable breeding herd following mass vaccination of sows with a modified live vaccine
- Expertise article
- Lebret et al.
In the last two decades, in France, Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) stabilization protocols have been implemented using mass vaccination with a modified live vaccine (MLV), herd closure and biosecurity measures.
Benefits of Family Oral Fluids vs Litter Oral Fluids
Learn about the Benefits of Family Oral Fluids vs Litter Oral Fluids
Which measurement is most likely to show if external biosecurity has been improved?
Episode 10 - Biosecurity: Online pathway to Pathogen Stop
Assessment of pulmonary tissue responses in pigs challenged with PRRSV Lena strain shows better protection after immunization with field than vaccine strains
- 32 minutes, 13 seconds
- Expertise article
- Thibaut Larchera, Christelle Fablet, Patricia Rensonb,c,d, Déborah Ménarde, Caroline Hervete, Georges Saadee, Catherine Belloce, Olivier Bourryb,c, François Meurense et. al.
Assessment pulmonary
Episode 7 - PRRS: Denmark runs large-scale area control project
- 28 minutes
- Podcast in Episodes
- Kristian Havn
“Sow farms that were virus positive when we started the programme are doing a lot better now... also, we have less airway disease in the growers and finisher pigs regarding problems that are secondary to PRRS”
Efficacy of a killed and modified live Porcine Reproductive and Respiratory
- Expertise article
- MR Roof, P Halbur, K Burkhart, E Vaughn
The purpose of this study was to evaluate the potential benefits of an autogenous killed PRRS product when used in combination with Ingelvac PRRS vaccine to protect against PRRSV challenge.
Ingelvac PRRS MLV provided heterologous protection, whereas the use of a killed autogenous PRRS vaccine alone or in combination failed to provide protection or any added benefit.